CAROLINE O'NEAL: Open Payments
NPI 1295862696 · OKLAHOMA CITY, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$205 in 10 payments from 8 companies in 2025. Trend: 2023 $50 · 2024 $155 · 2025 $205
Food & beverage: $205
| Company | Payments | Amount |
|---|---|---|
| Daiichi Sankyo Inc. | 3 | $67 |
| Agios Pharmaceuticals, Inc. | 1 | $23 |
| Novartis Pharmaceuticals Corporation | 1 | $22 |
| Legend Biotech USA Inc. | 1 | $22 |
| Janssen Biotech, Inc. | 1 | $20 |
| Biogen, Inc. | 1 | $19 |
| Bard Peripheral Vascular, Inc. | 1 | $17 |
| Geron Corporation | 1 | $15 |
Products named: INJECTAFER, PYRUKYND, Vanflyta, Fabhalta, CARVYKTI, TECVAYLI, TYSABRI, Trek.
Industry payments across OK — which companies pay providers there.
